OpenAlex
PricingAboutJobs
Log inGet started
Work

Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7–8% A1c levels. The TULIP study

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/j.1463-1326.2008.00980.x
Authors: J‐F. Blicklé, N. Hancu, M. Piletic, V. Profozic, M. Shestakova, M‐P. Dain, S. Jacqueminet, A. Grimaldi
Institutions: Hôpitaux Universitaires de Strasbourg, Iuliu Hațieganu University of Medicine and Pharmacy, Endocrinology Research Center, Sanofi (France), Pitié-Salpêtrière Hospital
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: insulin glargine, type 2 diabetes, glycemic control, lifestyle management, HbA1c, fasting blood glucose, metformin, sulfonylureas, early insulin initiation, weight loss, hypoglycemia, body mass index
SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Sanofi, Novo Nordisk, Servier
OpenAlex ID: W2050249722
FWCI: 4.104
Cites: 20
Cited by: 57
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security